Today I attended a MicroMedex 2.0 overview tutorial that was run here at the hospital by US representatives from MicroMedex Thomson Reuters. I suggested to the volunteer on work experience that she attend too as I thought it would be good experience being in the audience with clinicians and pharmacists – not just librarians. Listening to questions from a mixed audience can be really useful. On first glance without having played with the product myself, there are a few things I like about it and there are a few that I don’t. MicroMedex is a US product and so has all the FDA data included, which isn’t appropriate here. It would be a fantastic product if it was customisable to include information from the Therapeutic Goods Administration (TGA), the Pharmaceutical Benefits Advisory Committee (PBAC) and the Pharmaceutical Benefits Scheme (PBS). As it stands, you will have to use two or more products to get the necessary information. I can see people prefering to use MIMS over this product. On the other hand, if you wanted to do contraindications search with a range of pharmaceuticals, MicroMedex makes it easy to select your drug of interest and then select any amount of other drugs to find adverse effects. MicroMedex is also able to be searched in a variety of ways and it is easy to print a section of a detailed report rather than have to print the whole thing (which many people get frustrated with). The presenter referred to Google quite a few times, mostly in relation to how the search function is like Google. Well yes, but shouldn’t you try to encourage people to get smart about searching rather than remain lazy? I also noticed that the layout is rather like UpToDate (which must be a significant compeditor in this market). In the end though, my impressions are favourable and I’m looking forward to experimenting with it next time I have a drugs query.